We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

69 hedge funds and large institutions have $370M invested in Cogent Biosciences in 2020 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

438% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 8

307% more capital invested

Capital invested by funds: $91M → $370M (+$279M)

97% more funds holding

Funds holding: 35 → 69 (+34)

89.27% more ownership

Funds ownership: 23.86% → 113.14% (+89%)

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

Holders
69
Holders Change
+34
Holders Change %
+97.14%
% of All Funds
1.22%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.11%
New
43
Increased
17
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$18.1M
2
BI
BVF Inc
California
+$16.8M
3
LGM
Logos Global Management
California
+$13.7M
4
PA
Perceptive Advisors
New York
+$13.2M
5
GTC
Ghost Tree Capital
New York
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
-$9.14M
2
Millennium Management
Millennium Management
New York
-$2.82M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1M
4
ACP
Acuta Capital Partners
California
-$959K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$757K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$35.8M +$13.2M +1,200,000 +60%
LGM
2
Logos Global Management
California
$21.6M +$13.7M +1,245,500 +185%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$19.4M +$18.1M +1,651,080 +2,128%
ABG
4
Ally Bridge Group
New York
$18.2M +$17.8M +1,622,591 New
FFM
5
Fairmount Funds Management
Pennsylvania
$17.5M -$11 -1 -0%
BI
6
BVF Inc
California
$17.2M +$16.8M +1,532,282 New
PCH
7
Polar Capital Holdings
United Kingdom
$13.4M +$13.1M +1,189,900 New
GTC
8
Ghost Tree Capital
New York
$12.4M +$12.1M +1,100,000 New
VA
9
VR Adviser
New York
$12.2M -$11 -1 -0%
RCM
10
RA Capital Management
Massachusetts
$11.5M +$11.3M +1,025,641 New
DM
11
Deerfield Management
New York
$11.2M +$11M +1,000,000 New
HA
12
HHLR Advisors
Cayman Islands
$11.2M +$11M +1,000,000 New
Morgan Stanley
13
Morgan Stanley
New York
$10.4M +$10.1M +917,797 +7,869%
AVAI
14
Atlas Venture Associates IX
Massachusetts
$10.3M +$833K +75,812 +9%
AVAX
15
Atlas Venture Associates XI
Massachusetts
$10.3M +$10.1M +916,196 New
Vanguard Group
16
Vanguard Group
Pennsylvania
$9.64M +$7.89M +717,777 +510%
Citadel Advisors
17
Citadel Advisors
Florida
$9.62M +$9.35M +850,691 +13,609%
CC
18
Commodore Capital
New York
$8.54M +$8.35M +760,025 New
SFM
19
Sphera Funds Management
Israel
$8.26M +$8.08M +735,434 New
Invesco
20
Invesco
Georgia
$7.86M +$7.69M +700,000 New
O
21
OrbiMed
New York
$7.36M +$7.2M +655,000 New
DCM
22
Driehaus Capital Management
Illinois
$7.23M +$6.53M +594,068 +1,188%
CCM
23
Consonance Capital Management
New York
$6.85M +$6.7M +610,000 New
FCM
24
Farallon Capital Management
California
$6.74M +$6.59M +600,000 New
BlackRock
25
BlackRock
New York
$6.63M +$5.49M +500,038 +555%
1
2 3 4

COGT Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q4 2020, worth a combined $370M — up 307% from $91M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new COGT positions and 8 closed out — a net gain of 35 holders — while 17 added to existing stakes and 9 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $18.1M. The largest seller was Samsara BioCapital, cutting an estimated $9.14M.

  • 69 institutional investors held Cogent Biosciences (COGT) as of Q4 2020, up from 35 in Q3 2020.
  • Funds reported $370M of Cogent Biosciences stock for Q4 2020, up 307% quarter-over-quarter.
  • 43 funds opened new Cogent Biosciences positions in Q4 2020 and 8 closed out, a net change of +35 holders.
  • The largest Cogent Biosciences buyer in Q4 2020 was Janus Henderson Group, an estimated $18.1M added.
  • The largest Cogent Biosciences seller in Q4 2020 was Samsara BioCapital, an estimated $9.14M sold.

Based on aggregated 13F filings for Q4 2020.